FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The folding and maintenance of proteins in a correctly folded active form is essential to normal cellular function.Accumulation of misfolded proteins, due to mutations or to defects in cellular quality control mechanisms, can prevent them from performing their normal function or result in toxic intermediates.
Looking for a particular Foldrx Pharmaceuticals employee's phone or email?
Foldrx Pharmaceuticals Questions
The Foldrx Pharmaceuticals annual revenue was $5 million in 2026.
Todd Grinnell is the Director, Medical Liaison Group of Foldrx Pharmaceuticals.
1 people are employed at Foldrx Pharmaceuticals.
Foldrx Pharmaceuticals is based in Cambridge, Massachusetts.
The NAICS codes for Foldrx Pharmaceuticals are [42, 42421, 4242, 3254, 325, 32541, 32, 424].
The SIC codes for Foldrx Pharmaceuticals are [512, 51].
Top Foldrx Pharmaceuticals Employees
-
Todd Grinnell
Director, Medical Liaison Group at Foldrx Pharmaceuticals
Cambridge, MA, US22
Related Companies
